Thursday, November 17, 2011

J&J to Nix Toxins From Baby Products - Nov. 17, 2011

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, November 17, 2011 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Online Auction December 7 at 9 AM ET Featuring lab equipment from Bayer and other leading global firms! Lot catalog includes Applied BioSystems 3948 Nucleic Acid Synthesis and Purification System, Thermo Finnigan AQA Liquid Chromatography Mass Spectrometer, PTI SpectroFlurometer Laser Strobe System, Amersham Pharmacia Biotech AKTA Prime Protein Purification System and much more. Register and bid online!

Please click here for more information.
HeadHtml
•  Johnson & Johnson (JNJ) to Nix Toxins from Baby Products More...
•  UK's National Institute for Clinical Excellence (NICE) Rejects Eisai Inc. (ESALF.PK)'s Halaven Breast Cancer Med More...
More Drug Product News
HeadHtml
•  Pfizer Inc. (PFE)'s Vyndaqel® (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP) More...
More Drug Approval News
HeadHtml
•  FDA Panel Backs Pfizer Inc. (PFE) Vaccine for Adults More...
•  Chelsea Therapeutics, Inc. (CHTP) Announces FDA Acceptance of NDA for Filing and Designation of Priority Review of NORTHERA(TM) for the Treatment of Symptomatic NOH More...
More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Biothera Phase II Lung Cancer Trial Fully Enrolled More...
•  Ritter Pharmaceuticals, Inc. Completes Phase 2 Clinical Study of RP-G28 for the Treatment of Lactose Intolerance More...
•  Bristol-Myers Squibb Company (BMY) Release: Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes More...
•  Mitochondria Restructuring Protein Provides New Therapeutic Target for Heart Disease, Sanford-Burnham Medical Research Institute Study More...
•  Emergent BioSolutions (EBS) Initiates Pivotal Clinical Trial Evaluating a Three-Dose BioThrax Regimen for Post-Exposure Prophylaxis More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Quantifying the Value of Pipeline Pilot, the Accelrys Scientific Enterprise Platform

This white paper outlines the methodology, sources of value, and quantifiable results from bringing products to market faster, avoiding unproductive experiments, saving developer time, and more.

Request Now!
HeadHtml
•  Blood Type May Affect Stroke Risk, Brigham and Women's Hospital Study More...
•  Aspirin Cuts Some Cancer Risk 60 Percent, University of Southampton Study More...
•  High Vitamin D Levels Linked to Serious Heart Condition, Intermountain Medical Center Study More...
•  Losing Weight May Help Fight Gum Disease, Case Western Reserve University Study More...
•  Green Tea May Trim "Bad" Cholesterol, Western University of Health Sciences Study More...
More General Clinical Research News
Events

Better Antibodies Through Better Antigen Design

Join SDIX at the Boston Cambridge Marriott on December 8th, 2011 for a symposium focused on next generation antibody development. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process. In a series of talks, our scientists and collaborators will discuss this antigen design philosophy and provide case studies to demonstrate the effectiveness of this methodology. In particular, these talks will focus on the use of SDIX's proprietary Genomic Antibody Technology™ and its ability to deliver antibodies that match end users' requirements.

Please click here for more information.
Latest Market Insight

The Emerging Role of Postmarketing Clinical Research

• Assess the industry impact of recent regulatory developments in postmarketing commitment trials and surveillance studies.
• Identify how postmarketing strategies can enhance product differentiation, market development, and formulary coverage.
• Use detailed case studies to understand the influence of phase IV trials upon lifecycle management, indication expansion, and reimbursement.

Click Here for More Information.
Tower: Facebook
Top Jobs
BioForest (Seattle, Washington)

Verinata Health, Inc.
Clinical Account Manager - Sales
Responsible for growing market share for the Verinata prenatal test. This individual will focus on the implementation of sales strategy, achievement of financial milestones and introduction of new clinical technology within the defined territory.

Pharm Country (Princeton, New Jersey)

Otsuka America Pharmaceutical, Inc.
Associate Director, Clinical Outsourcing
Responsible for supporting OPDC Clinical Regulatory Teams (CRT) in selecting, negotiating costs, contracting and providing business oversight of CROs and other ancillary vendors. The position provides leadership in developing internal processes and standards

Biotech Bay (San Francisco, California)

Jennerex
Clinical Research Associate/Senior Clinical Research Associate
Oversees the conduct of assigned clinical studies including acting as liaison to clinical investigators & ensuring the quality and integrity of data. This position will independently perform clinical monitoring activities to ensure site compliance and adherence with study protocols, project plans, Jennerex SOPs, and FDA/ICH GCP regulations.

BioCapital (Bethesda, Maryland)

Technical Resources International
Clinical Information Specialist II
Primary responsibilities include the receipt and abstraction of protocol and/or contact information into the appropriate databases for use by the client and their collaborators in support of clinical trials.

BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Clinical Trial Manager / Sr. Clinical Trial Manager, Clinical Program Management
Responsible for the execution of Phase II - IV and other approved US and ex-US clinical studies, according to ICH-GCP and required regional regulations as applicable in support of the clinical strategies defined in the Takeda Integrated Development Plan Responsible for the execution of Phase II-IV and other (IDP).

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


BioSpace Life Science Career Fairs are the biotech industry's premier career events. Featuring well-respected employers from around the nation, our job fairs attract top candidates in the biotech, pharmaceutical, life science and medical device industries.

With such a great number of recruiters and hiring managers from top biotech companies attending our career fairs, there are an abundance of opportunities available for job seekers. Many different disciplines within the industry are represented bringing a diversity of candidates to our job fairs.

Companies seeking pharmaceutical sales representatives and marketing jobs regularly attend our job fairs. Engineering and technical jobs can be found, as well as regulatory jobs and positions in QA/QC. Individuals desiring a science job or a research job will find many opportunities at our job fairs. In addition, hiring managers seeking candidates for clinical research jobs also attend our events.

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Marina Biotech, Inc. (Formerly Known as MDRNA, Inc.) Granted Patent Rights in China for Intranasal Insulin Delivery Formulations More...
•  Genmab A/S (GEN.CO) Announces US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit More...
More Patent News
Feature

Hot Company

Gentris Corporation
133 Southcenter Court, Suite 400
Morrisville, North Carolina 27560 U.S.A.
Phone: 919-465-0100 Fax: 919-465-0554

Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services. As pioneers in the field of pharmacogenomics, Gentris assists pharmaceutical companies and clinical research organizations to effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective drugs to market more quickly.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2011 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: